News
‘A better picture’: First AACE guidelines on diabetes technology
Current knowledge on insulin pumps, continuous glucose monitors, automated insulin delivery systems, ‘smart’ pens, telemedicine, apps, and...
News
FDA panel endorses teplizumab for delaying type 1 diabetes
Teplizumab interferes with T cell–mediated autoimmune destruction of pancreatic beta cells.
News
‘Overbasalization’ common in type 2 diabetes management
There are alternatives to giving insulin before meals to...
News
Mild cortisol excess increases mortality in adrenal incidentaloma
Autonomous cortisol secretion level following dexamethasone suppression test in patients with adrenal incidentalomas, but without Cushing syndrome...
News
Obesity hope as neuropeptide Y blocker turns white fat to brown
Mouse studies suggest that the agent turns fat-storing white adipose tissue into fat-burning brown tissue, without brain involvement.
News
FDA clears cap device for ‘smart’ insulin pens for diabetes
The Bigfoot Unity System comprises a cap that attaches to insulin pens to provide CGM readings and dose recommendations for people with type 1 or...
News
In-hospital glucose management program gives dramatic savings
“I’ve been advocating for endocrine hospitalists to be deployed nationally,” said Dr. Misha Zilbermint.
News
Only a third of adults with diabetes receive ADA-recommended care
In 2017-2018, only one in three received all of five care elements recommended by the American Diabetes Association.
News
Promising data on once-weekly insulin, phase 3 study ongoing
New studies of the investigational once-weekly insulin icodec show it’s possible to switch from other basal insulins to icodec and that dose...
News
Cushing’s death rate ‘unacceptable,’ triple that of general population
Death rates among patients with endogenous Cushing’s syndrome have dropped since 2000 but are still threefold that of the general population.
News
FDA panel supports islet cell treatment for type 1 diabetes
Voting 12-4 to support approval, panel members expressed concern about toxicity of long-term immunosuppression, particularly given the advances in...
News
Fit-for-Fertility program boosts births, is cost effective
The cost in Canadian dollars per additional newborn achieved with the Fit-for-Fertility program was similar to the willingness-to-pay for in vitro...
News
FDA approves new ready-to-inject glucagon product
Dasiglucagon is the third of newer-generation glucagon products that don’t require multistep reconstitution in emergency hypoglycemic situations...